We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

Back to rankings

8 hedge funds and large institutions have $100K invested in Medovex Corp. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 6 → 8 (+2)

22% more capital invested

Capital invested by funds: $82K → $100K (+$18K)

0.84% more ownership

Funds ownership: 0% → 0.84% (+0.84%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MIC
Meridian Investment Counsel
California
+$62.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.8K
3
BFA
BlackRock Fund Advisors
California
+$577

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$54.5K
2
Citadel Advisors
Citadel Advisors
Florida
-$2.94K
3
Morgan Stanley
Morgan Stanley
New York
-$2

MDVX Hedge Fund Activity: Q1 2016 in Review

8 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q1 2016, worth a combined $100K — up 22% from $82K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDVX positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Meridian Investment Counsel, opening a new position worth an estimated $62.4K. The largest seller was UBS Group, cutting an estimated $54.5K.

  • 8 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q1 2016, up from 6 in Q4 2015.
  • Funds reported $100K of Medovex Corp. Common Stock stock for Q1 2016, up 22% quarter-over-quarter.
  • 2 funds opened new Medovex Corp. Common Stock positions in Q1 2016 and 0 closed out, a net change of +2 holders.
  • The largest Medovex Corp. Common Stock buyer in Q1 2016 was Meridian Investment Counsel, an estimated $62.4K added.
  • The largest Medovex Corp. Common Stock seller in Q1 2016 was UBS Group, an estimated $54.5K sold.

Based on aggregated 13F filings for Q1 2016.